Guardian Pharmacy Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

About this update from Guardian Pharmacy Services, Inc.

[{"type":"text","content":"ATLANTA, March 26, 2025--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. ("Guardian") (NYSE: GRDN), one of the nation’s largest long-term care (LTC) pharmacy services companies, today announced financial results for the fourth quarter and full year ended December 31, 2024.","length":285,"tagName":"p"},{"type":"text","content":"Fourth Quarter and Full Year Highlights","length":39,"tagName":"p"},{"type":"text","content":"Three Months Ended December 31, 2024","length":36,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue of $338.6 million, an increase of 20% year-over-year, driven by organic growth and the previously announced acquisitions of Heartland Pharmacy on April 1, 2024 and Freedom Pharmacy on November 1, 2024 (the "acquisitions").","length":240,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Resident Count of 186,000 at the end of the quarter, an increase of 14% year-over-year and up from 180,000 in the prior quarter, attributable to organic growth and the acquisitions.","length":181,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Net Income of $11.8 million, a decrease of $2.7 million year-over-year, attributable to changes in income tax provision expense, share-based compensation expense, and expense associated with certain legal and other regulatory matters.","length":234,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Adjusted EBITDA1 of $25.9 million, an increase of 30% year-over-year. Adjusted EBITDA was positively impacted by organic growth and efficiencies gained year-on-year in administering flu and COVID-19 vaccine clinics within LTC facilities we serve.","length":246,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":901,"olType":false},{"type":"text","content":"Year Ended December 31, 2024","length":28,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue of $1.228 billion, an increase of 17% year-over-year, driven by organic growth and the acquisitions.","length":108,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Net Income (loss) of ($71.0) million, a decrease of $108.8 million year-over-year, primarily attributable to $131.5 million of share-based compensation expense, $125.7 million of which was associated with the Company's Corporate Reo...

More updates from Guardian Pharmacy Services, Inc.